Literature DB >> 34159551

Neutrophil, Extracellular Matrix Components, and Their Interlinked Action in Promoting Secondary Pathogenesis After Spinal Cord Injury.

Sonam Dolma1, Hemant Kumar2.   

Abstract

Secondary pathogenesis following primary mechanical damage to the spinal cord is believed to be the ultimate reason for the limitation of currently available therapies. Precisely, the complex cascade of secondary events-mediated scar formation is the sole hurdle in the recovery process due to its inhibitory effect on axonal regeneration, plasticity, and remyelination. Neutrophils initiate this secondary injury along with other extracellular matrix components such as matrix metalloproteinase (MMPs), and chondroitin sulfate proteoglycans (CSPGs). Together, they mediate inflammation, necrosis, apoptosis, lesion, and scar formation at the injury site. Activated neutrophil releases several proteases, cytokines, and chemokines that cause complete tissue destruction. Thus, neutrophil activation and infiltration in the acute phase of injury act as a roadmap for inducing tissue destruction. MMPs, are extracellular proteolytic enzymes that degrade the ECM proteins, increases vascular permeability, and are predominantly released by neutrophils. These MMPs, in turn, cleave NG2 proteoglycan, a subtype of CSPG, into the active form. This active or shed form is involved in both the fibrotic as well as glial scar formation. Since neutrophils and ECM components are closely associated with each other in pathological conditions. Herein, we emphasize the interaction of neutrophils and their influence on ECM protein expression during the acute and chronic phases to identify a promising targets for designing a therapeutic approach in spinal cord injury.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chondroitin sulphate proteoglycan; Extracellular matrix; Matrix metalloproteinase; Neutrophils; Spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 34159551     DOI: 10.1007/s12035-021-02443-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  65 in total

1.  Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.

Authors:  Hemant Kumar; Min-Jae Jo; Hyemin Choi; Manjunatha S Muttigi; Seil Shon; Byung-Joo Kim; Soo-Hong Lee; In-Bo Han
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 2.  Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment.

Authors:  Sheri L Peterson; Aileen J Anderson
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

Review 3.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Authors:  Brian K Kwon; Elena Okon; Jessica Hillyer; Cody Mann; Darryl Baptiste; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-04-14       Impact factor: 5.269

4.  Traumatic spinal cord injury in the United States, 1993-2012.

Authors:  Nitin B Jain; Gregory D Ayers; Emily N Peterson; Mitchel B Harris; Leslie Morse; Kevin C O'Connor; Eric Garshick
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

5.  Do Patients with Complete Spinal Cord Injury Benefit from Early Surgical Decompression? Analysis of Neurological Improvement in a Prospective Cohort Study.

Authors:  Étienne Bourassa-Moreau; Jean-Marc Mac-Thiong; Ang Li; Debbie Ehrmann Feldman; Dany H Gagnon; Cynthia Thompson; Stefan Parent
Journal:  J Neurotrauma       Date:  2016-01-07       Impact factor: 5.269

Review 6.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Early complications of high-dose methylprednisolone in acute spinal cord injury patients.

Authors:  Borja Suberviola; Alejandro González-Castro; Javier Llorca; Fernando Ortiz-Melón; Eduardo Miñambres
Journal:  Injury       Date:  2008-06-09       Impact factor: 2.586

8.  Elevated TRPV4 Levels Contribute to Endothelial Damage and Scarring in Experimental Spinal Cord Injury.

Authors:  Hemant Kumar; Chang Su Lim; Hyemin Choi; Hari Prasad Joshi; Kyoung-Tae Kim; Yong Ho Kim; Chul-Kyu Park; Hwan Myung Kim; In-Bo Han
Journal:  J Neurosci       Date:  2020-01-23       Impact factor: 6.167

9.  Role of neutrophil elastase in compression-induced spinal cord injury in rats.

Authors:  Y Taoka; K Okajima; K Murakami; M Johno; M Naruo
Journal:  Brain Res       Date:  1998-07-20       Impact factor: 3.252

Review 10.  Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

Authors:  Haoqian Zhang; Mayland Chang; Christopher N Hansen; D Michele Basso; Linda J Noble-Haeusslein
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

View more
  3 in total

Review 1.  Graphene and graphene-based materials in axonal repair of spinal cord injury.

Authors:  Shi-Xin Wang; Yu-Bao Lu; Xue-Xi Wang; Yan Wang; Yu-Jun Song; Xiao Wang; Munkhtuya Nyamgerelt
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

Review 2.  Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.

Authors:  Małgorzata Zawadzka; Anna Kwaśniewska; Krzysztof Miazga; Urszula Sławińska
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 3.  Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury.

Authors:  Qi-Ming Pang; Si-Yu Chen; Sheng-Ping Fu; Hui Zhou; Qian Zhang; Jun Ao; Xiao-Ping Luo; Tao Zhang
Journal:  J Inflamm Res       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.